Chronology of Committee Work

Budget Cuts Threaten FDA's Enforcement Capacity

Rep. Waxman expresses concerns to FDA Acting Commissioner Dr. Lester Crawford that budget cuts proposed by the President will reduce the number of FDA employees and hamper already-faltering enforcement efforts.

Bill Would Restore Scientific Integrity to Research and Policymaking

Reps. Waxman and Gordon introduce H.R. 839, legislation to protect federal science from political interference. The bill includes bars on manipulating science, suppressing research, and using political litmus tests to appoint members of scientific advisory committees.

Data on Migrant Farmworkers Still Needed

Rep. Waxman and 18 other member of Congress urge the Department of Labor to continue the National Agricultural Workers Survey, which provides essential information on employment, immigration, health, public benefits, education, wages, and income.

Unanswered Questions Remain on Rice's Iraq Pick

Rep. Waxman asks for a full explanation of the role of Ambassador Dick Jones, Secretary of State Rice's choice to head U.S. Iraq policy, in the steering of a lucrative fuel contract to an obscure Kuwaiti company.

Chairmen Davis and Souder Mischaracterize Report's Position on Needle Exchange

In letters to Secretary of State Rice and USAID Administrator Natsios, Reps. Waxman and Cummings clarify the International Narcotics Control Board's position on the efficacy of needle exchange programs. Chairmen Davis and Souder had mischaracterized the report in previous correspondence.

GAO Reminds Agencies of Covert Propaganda Ban

The Comptroller General writes to all executive branch agency heads to advise them of the restrictions on spending for "publicity and propaganda," specifically noting the GAO's finding that some prepackaged news stories are illegal covert propaganda.

Justice Department Urged to Pursue Tobacco Suit Aggressively

Reps. Waxman and Meehan write to Attorney General Gonzales to express their support for the Justice Department's aggressive pursuit of the landmark case against the tobacco industry.

Waxman Requests Hearings into Baseball Steroid Use

In a letter to Chairman Davis, Rep. Waxman asks for congressional hearings into the allegations of steroid use in Major League Baseball and the adequacy of the league's response.

SSA Altered Communications to Undermine Confidence

A new report released by Reps. Waxman and other senior members of Congress details how the Social Security Administration has systematically altered its public communications.

Evidence Grows of Administration's Misuse of New Information Restrictions

In a letter calling for a congressional investigation, Rep. Waxman provides examples of how proliferating information designations such as "sensitive but unclassified" have been used to block the release of important government records.

HHS Questioned on Continued Use of Video News Releases

Reps. Waxman, Miller, and DeLauro write to HHS about a recent report that the agency continues to use prepackaged video news releases as part of the Department's public relations efforts.

DOD Contracts with ESSI "Appear to Have Anomalies in Them"

In a letter to Secretary Rumsfeld, Rep. Waxman asks for details of the Defense Department's contracts with Engineered Support Systems, Inc., on whose board William H.T. Bush, the President's uncle, sits. An Undersecretary of Defense has said the contracts "appear to have anomalies in them."

Committee to Investigate Awarding of No-Bid Contracts to Alaska Native Corporations

Chairman Davis and Rep. Waxman write Administration officials and GAO about the increasing number of no-bid federal contracts awarded to Alaska Native Corporations under special contracting provisions.

Lax Oversight of Medicaid Drug Pricing Costs Millions

Rep. Waxman releases a new GAO study that shows that the federal agency responsible for Medicaid has failed to ensure that the program get the "best possible" prices from prescription drug manufacturers, as required under law.

Audits Undermine Care for Children with Mental Illness

Rep. Waxman and Sen. Collins ask the HHS Inspector General and the Administrator of the Center for Medicare and Medicaid Services to halt an initiative to cut off federal funding for the medical treatment of children with severe mental illness.

Davis and Waxman Respond to MLB's Objections to Steroid Investigation

Chairman Davis and Rep. Waxman detail the basis for the Committee's investigation into steroid use and reject the premise that Major League Baseball and its players are above responsible scrutiny.

Pentagon Auditors Conclude Halliburton Overcharged $100 Million

Reps. Waxman and Dingell reveal that Defense Department auditors have determined, in a report withheld from Congress, that Halliburton overcharged by more than $100 million under its no-bid Iraq oil contract.

Administration Withheld Halliburton Overcharges from International Auditors

Rep. Waxman reveals that Administration officials, acting at the request of Halliburton, redacted a Pentagon report to conceal more than $100 million in fuel overcharges from international auditors overseeing the Development Fund for Iraq.

Davis and Waxman Question MLB Drug Policy

In a letter to baseball commissioner Bud Selig and players representative Donald Fehr, Chairman Davis and Ranking Member Waxman raise questions about baseball’s new steroid policy, including its penalties, scope, and implementation.

Civil Rights Commission Considers Biased Social Security Studies

Democratic Leader Pelosi, Rep. Waxman, and six other members of Congress express serious reservations about the U.S. Commission on Civil Rights' consideration of proposed studies on Social Security's impact on minorities that appear to be politically biased.

Committee Holds Hearing on Steroids in Baseball

Thursday, March 17, 10 a.m. EST -- The Government Reform Committee held a hearing into the allegations of steroid use in Major League Baseball and the adequacy of the league's response.

Davis and Waxman Reintroduce Legislation to Regulate Tobacco Products

Chairman Davis and Rep. Waxman introduce H.R. 1376, legislation that would give FDA strong authority to regulate tobacco products.

Rep. Waxman Releases Statement on Committee's Issuance of Subpeona for Terri Schiavo

Rep. Waxman: "These subpoenas are a flagrant abuse of power. Congress is turning the Schiavo family's personal tragedy into a national political farce. The committee has no business inserting itself in the middle of an excruciating private family matter."

OMB Questioned on Industry Group Meetings

Reps. Waxman and Lynch ask the Office of Management and Budget to release information on recent meetings with business community representatives to discuss proposals for changes to the regulatory process.

Committee Seeks Records on NFL Steroid Testing

Chairman Davis and Rep. Waxman request copies of the steroid policies of the National Football League and summaries of the league’s steroid testing results.

Displaying Items 26 to 50 of 202:

Previous Page • Next Page

[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9]